MALAGA, Spain—Patients with obesity treated with the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide (Wegovy; Novo Nordisk) can achieve weight loss in the real world similar to what has ...
A 24-week telehealth program combining long-acting anti-obesity medications (AOMs) with tailored virtual behavioral support lead to meaningful weight loss and blood pressure reductions among ...
Switching to the oral small molecule glucagon-like peptide-1 (GLP-1) orforglipron after taking injectable GLP-1s helped patients maintain most - but ...
A meta-analysis involving more than 43,000 adults with obesity, suggests that obesity medications, such as GLP-1 drugs, could ...
The Healthy @Reader's Digest on MSN
Want to lose weight and strengthen your bones? Wear this piece of clothing, says a new study
The study population saw noted payoff when they paired this trending apparel with another crucial activity.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results